ResMed Inc. (RMD) is a publicly traded Healthcare sector company. As of August 25, 2026, RMD trades at $237.08 with a market cap of $33.40B and a P/E ratio of 22.15. RMD moved +2.24% today. Year to date, RMD is -3.50%; over the trailing twelve months it is -20.86%. Its 52-week range spans $180.27 to $293.81. Analyst consensus is buy with an average price target of $238.50. Rallies surfaces RMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $237.08 |
| Market Cap | $33.40B |
| P/E Ratio | 22.15 |
| EPS | $10.47 |
| Dividend Yield | 0.66% |
| 52-Week High | $293.81 |
| 52-Week Low | $180.27 |
| Volume | 950.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.65B |
| Net Income | $1.52B |
| Gross Margin | 61.06% |
15 analysts cover RMD: 0 strong buy, 4 buy, 11 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $238.50.